Adamis Pharmaceuticals Stock Price

0.0249 (3.61%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 1,290,208
Bid Price 0.715
Ask Price 0.7298
News -
Day High 0.7398


52 Week Range


Day Low 0.69
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Adamis Pharmaceuticals Corporation ADMP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0249 3.61% 0.715 19:50:34
Open Price Low Price High Price Close Price Prev Close
0.695 0.69 0.7398 0.7133 0.6901
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,172 1,290,208 $ 0.7178978 $ 926,237 - 0.47 - 2.34
Last Trade Time Type Quantity Stock Price Currency
18:49:21 formt 2,000 $ 0.715 USD


Draw Mode:

Adamis Pharmaceuticals Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 106.45M 148.89M 148.04M $ 16.53M $ - -0.64 -1.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 50.00k 5.70%

more financials information »

Adamis Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADMP Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.770.83960.64740.74044462,528,068-0.055-7.14%
1 Month1.031.07990.64740.88696113,078,951-0.315-30.58%
3 Months1.101.480.64741.116,365,865-0.385-35.0%
6 Months1.101.480.64741.095,861,318-0.385-35.0%
1 Year0.50482.340.471.199,170,8540.210241.64%
3 Years2.903.290.271.094,418,660-2.19-75.34%
5 Years2.906.450.271.382,946,830-2.19-75.34%

Adamis Pharmaceuticals Description

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. Its products and product candidates in the allergy, respiratory, and opioid overdose markets include SYMJEPI (epinephrine) Injection 0.3mg and Injection 0.15mg for use in the emergency treatment of acute allergic reactions, including anaphylaxis; a naloxone injection product candidate, ZIMHI, based on the approved Symject injection device and intended for the treatment of opioid overdose; Tempol, an investigational drug; and a Beclomethasone metered dose inhaler product candidate (APC-1000) intended for the treatment of asthma.
Your Recent History
Adamis Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211208 03:51:04